MWAIOTCFinance ServicesUS GAAP · USD

MedWellAI, Inc.

MedWellAI, Inc. is a Nevada-based holding company that has shifted from its earlier digital-asset/mining focus into AI-enabled healthcare and wellness businesses. Through subsidiaries such as MedWell USA and MedWell Facilities, it sells pharmaceutical products, supports provider ordering workflows, and pursues wellness-related real estate and service opportunities.

Kysy yhtiöstä
Liikevaihto0,5milj. USD
−11,2 %v/v
Liikevoitto (EBIT)−1,2milj. USD
+56,5 %v/v
EBIT-marginaali−234,2%
+243,3 %-yks.v/v
Nettotulos−1,6milj. USD
+55,9 %v/v
Vapaa kassavirta−0,3milj. USD
+63,9 %v/v

Tilikausi 2026 · muutos edellisvuodesta

Kehitys 2021–2026

−30−20−10010milj. USD2021: 1,9 milj. USD2021: EBIT −22 milj. USD20212022: 6,6 milj. USD2022: EBIT −0,69 milj. USD20222023: 3,9 milj. USD2023: EBIT −25 milj. USD20232024: 5,9 milj. USD2024: EBIT −11 milj. USD20242025: 0,59 milj. USD2025: EBIT −2,8 milj. USD20252026: 0,53 milj. USD2026: EBIT −1,2 milj. USD20260,53−1,2
LiikevaihtoLiikevoitto (EBIT)
Kysy Clarifolta: MedWellAI, Inc.

Liiketoiminta

Osuus liikevaihdosta
Pharmaceutical product sales85 %

Bulk sale and distribution of GLP medications for weight loss and diabetes management.

Commission and service revenue5 %

Commissions and service fees tied to customer transactions and consultation-enabled offerings.

Online sales1 %

Legacy online sales activity that management has said it is no longer pursuing due to regulatory hurdles.

Rental income4 %

Lease and sub-lease income from properties used in the wellness and healthcare ecosystem.

Holding company and investment activities5 %

Corporate-level acquisition, investment, and development activities that support new business lines.

Asiakkaat

The company sells primarily to healthcare-related business customers rather than consumers, especially doctors’ offices, clinics, med spas, and corporate wellness facilities. It also works with affiliated medical groups and licensed providers to support consultation-enabled transactions, which makes the customer base dependent on both product demand and clinical workflow integration.

Healthcare provider offices

Doctors' offices and similar practices buy GLP medications and related services for patient use and recurring supply needs.

Wellness clinics and med spas

These customers use the platform to source products and streamline ordering for weight-loss and wellness programs.

Corporate wellness facilities

Corporate wellness operators buy products and services to support employee wellness offerings.

Affiliated medical groups and providers

Licensed providers deliver consultations that enable the company’s service revenue and prescription-related workflow.

Strategia

Management is repositioning the company around AI-driven healthcare and wellness after earlier digital-asset activities. Near-term priorities appear to be building the MedWell platform, expanding pharmaceutical distribution, and monetizing wellness-related facilities while avoiding business lines that face regulatory friction.

Build the MedWell healthcare platformLyhyt aikaväli

The company needs a scalable operating base beyond legacy holdings and digital-asset activities.

Expand provider-facing distribution relationshipsKeskipitkä aikaväli

Revenue depends on repeat purchasing from clinics and offices that need reliable supply and support.

Develop wellness facilities and real estateKeskipitkä aikaväli

Facilities can create a broader ecosystem around healthcare customers and diversify revenue streams.

Avoid regulatory-heavy online sales modelsLyhyt aikaväli

Management has already said it is no longer pursuing the online sales business due to regulatory hurdles.

Maantiede

MedWellAI is headquartered in the United States and its disclosed operations are centered in Nevada and Florida through its subsidiaries and acquired interests. The filings do not provide a meaningful country-by-country revenue split, but the business appears to be U.S.-focused and exposed to U.S. healthcare and pharmaceutical regulation.

Riskit

The company remains early-stage, loss-making, and dependent on external financing, so execution risk is high. It also faces customer concentration, regulatory risk in healthcare/pharmaceutical distribution, and technology/compliance risk from using AI in a regulated environment.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Going concern / financing risk1Customer concentration2Key-person dependence3AI and technology risk5
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Going concern / financing riskVaikutus: KriittinenTodennäköisyys: Korkea

    The company has a history of losses and states it may need additional capital to continue operations.

    Kohdistuu: Liquidity and solvency

  2. Customer concentrationVaikutus: KorkeaTodennäköisyys: Kohtalainen

    One customer generated about 96% of revenue, so the loss of that customer would materially reduce sales.

    Kohdistuu: Revenue concentration

  3. Key-person dependenceVaikutus: KorkeaTodennäköisyys: Kohtalainen

    The CEO is the sole officer and director, so loss of that person would impair management continuity.

    Kohdistuu: Leadership and execution

  4. Regulatory risk in healthcare and online salesVaikutus: Korkea

    Management discontinued online sales due to regulatory hurdles, showing the business model is sensitive to compliance constraints.

    Kohdistuu: Product distribution and sales channels

  5. AI and technology riskVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    AI tools in healthcare can create privacy, bias, cybersecurity, and regulatory issues that may disrupt operations.

    Kohdistuu: Platform and workflow tools

Kysy Clarifolta: MedWellAI, Inc.

Kirjanpito

Harkinnanvaraiset erät
Revenue recognition under ASC 606

The company recognizes product sales at delivery and service revenue as principal, which affects timing and gross presentation.

Vaikutus: Can shift revenue between periods and affect reported margins

Deferred revenue

Customers pay at order placement before delivery, so cash receipts are recorded as deferred revenue until performance is complete.

Vaikutus: Affects working capital and near-term revenue timing

Goodwill impairment

Goodwill tied to the acquired online sales business was fully impaired when management stopped pursuing that line.

Vaikutus: Can create large non-cash charges and reduce equity

Lease accounting

Rental income from sub-leased properties is recognized straight-line over the lease term under lease accounting rules.

Vaikutus: Affects revenue timing and asset/liability presentation

Stock-based compensation

Equity awards are measured at grant-date fair value and expensed over service periods.

Vaikutus: Can materially affect operating expenses and dilution

Samankaltaisia listattuja yhtiöitä

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Goldenwell Biotech, Inc.

GWLL · Food and Kindred Products

CorVel Corp

CRVL · Insurance Agents, Brokers & Service

Medtronic plc

MDT · Electromedical & Electrotherapeutic Apparatus

Healthcare AI Acquisition Corp.

Blank Checks

Stagwell Inc

STGW · Services-Advertising Agencies

American Well Corp

AMWL · Services-Business Services, NEC

Päivitetty: 24.9.2026

MedWellAI, Inc. (OTC) – Finance Services | Analyysi – Clarifo